Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An aggressive malignant smooth muscle neoplasm. It is characterized by the presence of malignant smooth muscle cells with granular cytoplasmic changes.
Biomarker and diagnostic research for granular cell leiomyosarcoma has been reported in the published literature.
No clinical trials have been registered for granular cell leiomyosarcoma.
4 publications have been identified in PubMed for granular cell leiomyosarcoma. Research spans Diagnostic / Biomarker (25%), Review / Meta-Analysis (25%), and Clinical Trial Publication (25%).
Akahoshi K (2025). [PMID: 39385518](https://pubmed.ncbi.nlm.nih.gov/39385518/). *Clinical endoscopy*. [Clinical Trial Publication]
Ortiz Requena D (2024). [PMID: 38876200](https://pubmed.ncbi.nlm.nih.gov/38876200/). *Human pathology*. [Epidemiology / Natural History]
Boroojerdi S (2024). [PMID: 38757248](https://pubmed.ncbi.nlm.nih.gov/38757248/). *APMIS : acta pathologica, microbiologica, et immunologica Scandinavica*. [Diagnostic / Biomarker]
Li W (2024). [PMID: 39560558](https://pubmed.ncbi.nlm.nih.gov/39560558/). *Medicine*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 3:56 AM UTC